Second-Generation Peptidomimetic Inhibitors of Protein Farnesyltransferase Demonstrating Improved Cellular Potency and Significant in Vivo Efficacy
- 25 August 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 42 (18) , 3701-3710
- https://doi.org/10.1021/jm9901935
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Inhibition of transforming growth factor-β2 expression with phosphorothioate antisense oligonucleotides in U937 cellsBioorganic & Medicinal Chemistry Letters, 1999
- Potent and Selective Non-Cysteine-Containing Inhibitors of Protein FarnesyltransferaseJournal of Medicinal Chemistry, 1998
- N-Arylalkyl Pseudopeptide Inhibitors of FarnesyltransferaseJournal of Medicinal Chemistry, 1998
- Inhibitors of Farnesyl Protein Transferase. 4-Amido, 4-Carbamoyl, and 4-Carboxamido Derivatives of 1-(8-Chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-Bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazineJournal of Medicinal Chemistry, 1998
- Section Review Oncologic, Endocrine & Metabolic: Farnesyl-protein transferase inhibitors in early developmentExpert Opinion on Investigational Drugs, 1996
- Palladium-Catalyzed Cross-Coupling Reactions of Organoboron CompoundsChemical Reviews, 1995
- Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeuticCell, 1994
- Benzodiazepine Peptidomimetics: Potent Inhibitors of Ras Farnesylation In Animal CellsScience, 1993
- All ras proteins are polyisoprenylated but only some are palmitoylatedCell, 1989
- ras GENESAnnual Review of Biochemistry, 1987